Overview

Europe Platelet Rich Plasma Market is poised to register a CAGR of over 7.1% during the forecast period 2022 to 2028.

Platelet-rich plasma, also known as autologous conditioned plasma, is a concentrate of platelet-rich plasma protein derived from whole blood, centrifuged to remove red blood cells. Europe platelet rich plasma market includes market size for platelet-rich plasma systems and platelet-rich plasma kits. 

The market report includes Europe platelet-rich plasma market value analysis by product type, applications, end user and country.  

PRP Systems 

Platelet-rich plasma systems included in this report are centrifuge systems specifically for separation of platelet-rich plasma and platelet poor plasma from autologous blood samples drawn at the point-of-care facility.  

Other centrifuge systems which have application in other cellular therapies and preparation of substances derived from body fluids are excluded from the scope of this report 

Examples of PRP systems included in this report are GPS® III Platelet Concentration System (Zimmer Biomet), The Arthrex ACP® Double Syringe System (Arthrex Inc), Arthrex Angel® cPRP Processing System (Arthrex Inc.) etc. among others 

PRP Kits 

PRP kits considered in this segment of the report include PRP preparation kits and PRP harvest kits. PRP Kit that makes Platelet-Rich Plasma extractions simple and cost-efficient 

PRP preparation and harvest kits generally include PRP Tubes, Re-Suspension Tube, injectors, needles, phlebotomy sets etc. 

PRP kits are made available to end users through three prominent sales channels. Sales channels included in this report are Direct Sales Channels, Distributor Sale Channels, and Others (group purchasing organisations, wholesalers, pharmacists etc.) 

Market Dynamics:  

• Sales Channel 

Being low margin product, direct sales channel sub-segment of PRP kits product type is the most popular    

• End User  

All clinics segments collectively experience high demand for PRP kits in Europe 

• Applications 

High demand for PRP kits is from cosmetic applications, including Skin rejuvenation, scar treatment, skin firming & whitening, fat grafting, hair loss treatment etc.  

 In U.K., PRP treatment industry is well established. However, there's limited presence of domestic manufacturers of PRP kits in U.K. Hence, PRP kits are availed in the country through distributors that have partnership with manufacturing companies 

Key market players are Terumo BCT, Zimmer Biomet, NeoGenesis Co. Ltd, Glofinn oy Overview, T Biotechnology (T Lab), Regen Lab SA, SDD Medical Group Ltd Overview, IntraVita International Limited Overview, Exactech Inc., Arthrex Inc., Biotechnology Institute (bti).

Europe Platelet Rich Plasma Market Segmentation  

By Product Type 
• Instruments
• Kits
  o Kit By Type
    • Pure Platelet-Rich Plasma (P-PRP)
    • Leukocyte-Rich Platelet-Rich Plasma (L-PRP)
    • Leukocyte-Platelet-Rich Fibrin (L-PRF)
    • Pure Platelet-Rich Fibrin (P-PRF)
  o Kit By Origin
    • Autologous Platelet-Rich Plasma
    • Homologus Platelet-Rich Plasma
    • Allogeneic Platelet-Rich Plasm

By Application 

• Cosmetic/Aesthetic/Hair Fall Treatment 
• Orthopedics/Rehabilitation medicine 
• Dentistry 
• Ophthalmology 
• Research and Development 
• Veterinary 

By End Users 

• Physician's office/Private Practice/Veterinary Clinics 
• Hospitals 
• Orthopedic Clinics 
• Cosmetic/dermatology/Trichology Clinics 
• Academic & Research Institutes 

By Region 

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:   

• Tier 1 players- established companies in the market with major market share   
• Tier 2 players  
• Emerging players which are growing rapidly  
• New Entrants   

FutureWise Takeaways   

• Growth prospects   
• SWOT analysis  
• Key trends  
• Key datapoints affecting market growth   

Objectives of the Study:  

• To provide with an exhaustive analysis on Europe platelet rich plasma market by product, application, end-user and region    
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)  
• To evaluate and forecast micro-markets and overall market   
• To predict market size, in five key regions (along with countries)—North America, Europe, Asia Pacific, and Latin America, Middle East and Africa  
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions  
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies   

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
   1.1. Objectives of the Study 
   1.2. Market Definition 
   1.3. Market Scope 
        1.3.1. Years Considered for the Study
        1.3.2. Market Covered
   1.4. Currency 
   1.5. Limitations 
   1.6. Stakeholders 

2. Research Methodology 
   2.1. Research Data 
        2.1.1. Secondary Data
               2.1.1.1. Key Data from Secondary Sources
        2.1.2. Primary Data
               2.1.2.1. Key Data from Primary Sources
   2.2. Market Size Estimation 
   2.3. Market Breakdown and Data Triangulation 
   2.4. Assumptions for the Study  

3. Executive Summary
   3.1. Market Outlook
   3.2. Segment Outlook
   3.3. Competitive Insights

4. Europe Platelet Rich Plasma Market Variables, Trends & Scope
   4.1. Market Lineage Outlook
   4.2. Penetration and Growth Prospect Mapping
   4.3. Industry Value Chain Analysis
   4.4. Cost Analysis Breakdown
   4.5. Technology Overview
   4.6. Regulatory Framework
        4.6.1. Reimbursement Framework
        4.6.2. Standards and Compliances

5. Market Overview
   5.1. Market Dynamics
        5.1.1. Market Driver Analysis
               5.1.1.1. Increasing focus of Europe Platelet Rich Plasma Market Companies on Brand Protection
               5.1.1.2. Untapped Opportunities in Emerging Regions
        5.1.2. Market Restraint Analysis
               5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
        5.1.3. Industry Challenges
               5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Europe Platelet Rich Plasma Market Analysis Tools
   6.1. Industry Analysis - Porter’s
        6.1.1. Supplier Power
        6.1.2. Buyer Power
        6.1.3. Substitution Threat
        6.1.4. Threat from New Entrants
        6.1.5. Competitive Rivalry
   6.2. Pestel Analysis
        6.2.1. Political Landscape
        6.2.2. Environmental Landscape
        6.2.3. Social Landscape
        6.2.4. Technology Landscape
        6.2.5. Legal Landscape
   6.3. Major Deals And Strategic Alliances Analysis
        6.3.1. Joint Ventures
        6.3.2. Mergers and Acquisitions
        6.3.3. Licensing and Partnership
        6.3.4. Technology Collaborations
        6.3.5. Strategic Divestments
   6.4. Market Entry Strategies
   6.5. Case Studies

7. Europe Platelet Rich Plasma Market, By Product Type Historical Analysis and Forecast 2022-2028 (USD Million)
           7.1. Instruments
           7.2. Kits
                 7.2.1. Kit By Type
                          7.2.1.1. Pure Platelet-Rich Plasma (P-PRP)
                          7.2.1.2. Leukocyte-Rich Platelet-Rich Plasma (L-PRP)
                          7.2.1.3. Leukocyte-Platelet-Rich Fibrin (L-PRF)
                          7.2.1.4. Pure Platelet-Rich Fibrin (P-PRF)
                 7.2.2. Kit By Origin
                          7.2.2.1. Autologous Platelet-Rich Plasma
                          7.2.2.2. Homologus Platelet-Rich Plasma
                          7.2.2.3. Allogeneic Platelet-Rich Plasma

8. Europe Platelet Rich Plasma Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)
           8.1. Cosmetic/Aesthetic/Hair Fall Treatment 
           8.2. Orthopedics/Rehabilitation medicine 
           8.3. Dentistry 
           8.4. Ophthalmology 
           8.5. Research and Development 
           8.6. Veterinary 

9. Europe Platelet Rich Plasma Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million)
           9.1. Physician's office/Private Practice/Veterinary Clinics     
           9.2. Hospitals 
           9.3. Orthopedic Clinics 
           9.4. Cosmetic/dermatology/Trichology Clinics 
           9.5. Academic & Research Institutes 

10. North America Europe Platelet Rich Plasma Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    10.1. Introduction
    10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          10.2.1. U.S.A
          10.2.2. Canada
          10.2.3. Mexico
    10.3. Market Size (USD Million) Forecast for North America 2022-2028

11. Latin America Europe Platelet Rich Plasma Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    11.1. Introduction
    11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          11.2.1. Brazil
          11.2.2. Venezuela
          11.2.3. Argentina
          11.2.4. Rest of Latin America
    11.3. Market Size (USD Million) Forecast for Latin America 2022-2028

12. Europe Europe Platelet Rich Plasma Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    12.1. Introduction
    12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          12.2.1. Germany
          12.2.2. U.K         
          12.2.3. France
          12.2.4. Italy
          12.2.5. Spain
          12.2.6. Russia
          12.2.7. Poland
          12.2.8. Rest of Europe
    12.3. Market Size (USD Million) Forecast for Europe 2022-2028

13. Asia Pacific Europe Platelet Rich Plasma Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    13.1. Introduction
    13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          13.2.1. Japan
          13.2.2. China
          13.2.3. India
          13.2.4. Australia and New Zealand
          13.2.5. ASEAN
          13.2.6. Rest of Asia Pacific
    13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    14.1. Introduction
    14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          14.2.1. GCC
          14.2.2. Israel
          14.2.3. South Africa
          14.2.4. Rest of MEA
    14.3. Market Size (USD Million) Forecast for MEA 2022-2028

15. Market Share Analysis and Competitive Landscape   
    15.1. Global Landscape - Key Players, Revenue and Presence
    15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    15.3. Global Emerging Companies
    15.4. North America - Market Share Analysis and Key Regional Players
    15.5. Europe - Market Share Analysis and Key Regional Players
    15.6. Asia Pacific - Market Share Analysis and Key Regional Players
    15.7. Global Key Player - Growth Matrix

16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
           16.1. Terumo BCT
                     16.1.1. Company Overview
                     16.1.2. Product Portfolio
                     16.1.3. SWOT Analysis
                     16.1.4. Financial Overview
                     16.1.5. Strategic Overview
           16.2. Zimmer Biomet
                     16.2.1. Company Overview
                     16.2.2. Product Portfolio
                     16.2.3. SWOT Analysis
                     16.2.4. Financial Overview
                     16.2.5. Strategic Overview
           16.3. NeoGenesis Co. Ltd
                     16.3.1. Company Overview
                     16.3.2. Product Portfolio
                     16.3.3. SWOT Analysis
                     16.3.4. Financial Overview
                     16.3.5. Strategic Overview
           16.4. Glofinn oy Overview
                     16.4.1. Company Overview
                     16.4.2. Product Portfolio
                     16.4.3. SWOT Analysis
                     16.4.4. Financial Overview
                     16.4.5. Strategic Overview
           16.5 T Biotechnology (T Lab),  
                     16.5.1. Company Overview
                     16.5.2. Product Portfolio
                     16.5.3. SWOT Analysis
                     16.5.4. Financial Overview
                     16.5.5. Strategic Overview
           16.6  Regen Lab SA
                     16.6.1. Company Overview
                     16.6.2. Product Portfolio
                     16.6.3. SWOT Analysis
                     16.6.4. Financial Overview
                     16.6.5. Strategic Overview
           16.7. SDD Medical Group Ltd Overview
                     16.7.1. Company Overview
                     16.7.2. Product Portfolio
                     16.7.3. SWOT Analysis
                     16.7.4. Financial Overview
                     16.7.5. Strategic Overview
           16.8. IntraVita International Limited Overview
                     16.8.1. Company Overview
                     16.8.2. Product Portfolio
                     16.8.3. SWOT Analysis
                     16.8.4. Financial Overview
                     16.8.5. Strategic Overview
           16.9. Exactech Inc.
                     16.9.1. Company Overview
                     16.9.2. Product Portfolio
                     16.9.3. SWOT Analysis
                     16.9.4. Financial Overview
                     16.9.5. Strategic Overview
           16.10. Arthrex Inc
                     16.10.1. Company Overview
                     16.10.2. Product Portfolio
                     16.10.3. SWOT Analysis
                     16.10.4. Financial Overview
                     16.10.5. Strategic Overview
           16.16.  Biotechnology Institute (bti
                     16.16.1. Company Overview
                     16.16.2. Product Portfolio
                     16.16.3. SWOT Analysis
                     16.16.4. Financial Overview
                     16.16.5. Strategic Overview

17. Pre and Post COVID-19 Impact
    17.1. Positive influence on the healthcare industry
    17.2. The financial disruption of the manufacturing sector
    17.3. Impact of COVID-19 on emerging companies
    17.4. Significant mandates in the regulations initiated by healthcare administrations
    17.5. The overall economic slowdown of the developing and developed nations

18. FutureWise SME Key Takeaway Points for Client
 

Tables

Figures